SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000905148-24-000531
Filing Date
2024-02-09
Accepted
2024-02-09 16:34:30
Documents
2
Period of Report
2024-02-08

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 1434
2 poa.htm EX-24 11344
  Complete submission text file 0000905148-24-000531.txt   14342
Mailing Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139
Business Address
Magovcevic-Liebisch Ivana (Reporting) CIK: 0001279281 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41551 | Film No.: 24615601

Mailing Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472 617-207-8979
Acrivon Therapeutics, Inc. (Issuer) CIK: 0001781174 (see all company filings)

IRS No.: 825125532 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)